NEW YORK (GenomeWeb) – About eight million people worldwide are infected with Trypanosoma cruzi, the parasite that causes Chagas disease, but research into epidemiology and treatment of this neglected tropical disease has been hampered by the lack of ideal molecular tests.
Now, scientists in Argentina have developed a multiplex PCR assay that may simplify the process, and have demonstrated its potential by typing a large set of international samples.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
